Impact of Advanced Therapy Medicinal Products status in European regulations on their production cost: The case of hematopoietic stem cells
{{output}}
Objectives: The therapeutic promises of somatic cell and gene therapy (Advanced Therapy Medicinal Products - ATMP) and the significant current or future costs of such therapies raise questions about the impact of European health ... ...
